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3-(4-chlorophenyl)-3-(5-methoxy-1H-indol-3-yl)-1-(1-methyl-1H-imidazol-2-
yl)propan-1-one (3b).1 Purified by column chromatography (SiO2, 50% 
EtOAc:hexanes). 1H-NMR (CD3OD, 400 MHz) δ 3.69 (s, 3H), 3.71 (dd, 1H, J = 16.8 Hz, 
J = 8.1 Hz), 3.85 (s, 3H), 3.88 (dd, 1H, J = 16.5 Hz, J = 7.5 Hz), 4.92 (t, 1H, J = 7.9 Hz), 
6.70 (dd, 1H, J = 8.7 Hz, J = 2.3 Hz), 6.77 (d, 1H, J = 2.3 Hz), 7.12 (s, 2H),  7.18 (d, 1H, 
J = 8.9 Hz), 7.21 (d, 2H, J = 8.4 Hz), 7.27 (s, 1H), 7.31 (d, 2H, J = 8.4 Hz). 13C-NMR 
(CDCl3, 400 MHz) δ 36.0 (q), 37.4 (d), 45.0 (t), 55.7 (q), 101.1 (d), 111.7 (d), 111.9 (d), 
118.3 (s), 122.0 (d), 122.1 (d), 126.8 (s), 127.1 (d), 128.3 (d), 128.8 (d), 129.2 (d), 131.7 
(d), 142.8 (s), 142.9 (s), 153.6 (s), 190.6 (s). HRMS (ESI) calcd for C22H21N3O2Cl: 
394.1317 ([M+H])+, found 394.1314 ([M+H])+. HPLC: Chiralcel-OD, heptane/iPrOH 
90:10,  flow 1 mL/min, tr 24.6 (+), 28.3 (-) mins. 
 
3-(5-methoxy-1H-indol-3-yl)-3-(4-methoxyphenyl)-1-(1-methyl-1H-imidazol-2-
yl)propan-1-one (3d).1 Purified by column chromatography (SiO2, 50% 
EtOAc:hexanes). 1H-NMR (CD3OD, 400 MHz) δ 3.64 – 3.70 (m, 1H), 3.68 (s, 3H), 3.69 
(s, 3H), 3.80 (s, 3H), 3.85 (dd, 1H, J = 15.7 Hz, J = 7.6 Hz), 4.84 – 4.88 (m, 1H), 6.68 
(dd, 1H, J = 8.8 Hz, J = 2.4 Hz), 6.74 – 6.78 (m, 3H), 7.09 (d, 2H, J = 6.5 Hz), 7.16 (d, 
1H, J = 8.8 Hz), 7.21 (s, 1H), 7.22 (d, 2H, J = 7.3 Hz). 13C-NMR (CDCl3, 400 MHz) δ 
36.1 (q), 37.4 (d), 45.5 (t), 55.2 (q), 55.8 (q), 101.5 (d), 111.6 (d), 112.0 (d), 113.7 (d), 
119.4 (s), 122.1 (d), 126.9 (s), 127.2 (d), 128.8 (d), 128.9 (d), 131.7 (s), 136.4 (s), 143.2 
(s), 153.7 (s), 157.8 (s), 191.2 (s). HRMS (ESI) calcd for C23H24N3O3: 390.1812 
([M+H])+, found 390.1813 ([M+H])+. HPLC: Chiralcel-AD, heptane/iPrOH 80:20, flow 1 
mL/min, tr 32.2 (-), 42.1 (+) mins. 
 
1-(1-methyl-1H-imidazol-2-yl)-3-(1-methyl-1H-indol-3-yl)-3-phenylpropan-1-one 
(3e).1 Purified by column chromatography (SiO2, 50% EtOAc:hexanes). 1H-NMR 
(CD3OD, 400 MHz) δ 3.69 (s, 3H), 3.74 (dd, 1H, J = 16.0 Hz, J = 8.0 Hz), 3.80 (s, 3H), 
3.87 (dd, 1H, J = 15.9 Hz, 7.5 Hz), 4.95 (t, 1H, J = 7.8 Hz), 6.90 (t, 1H, J = 7.2 Hz), 7.04 
(s, 1H), 7.06 – 7.11 (m, 2H), 7.11 (s, 1H), 7.17 – 7.25 (m, 4H), 7.31 – 7.34 (m, 3H). ). 
13C-NMR (CDCl3, 400 MHz) δ 32.7 (q), 36.1 (q), 38.0 (d), 45.5 (t), 109.0 (d), 117.9 (s), 
118.7 (d), 119.6 (d), 121.5 (d), 126.0 (d), 126.2 (d), 126.8 (d), 127.2 (d), 127.9 (s), 128.3 
(d), 129.0 (d), 137.2 (s), 143.2 (s), 144.6 (s), 191.1 (s). HPLC: Chiralcel-ODH, 
heptane/iPrOH 90:10, flow 0.5 mL/min,  tr 23.2 (+) and 27.5 (-) mins. 
 
3-(5-methoxy-1H-indol-3-yl)-1-(1-methyl-1H-imidazol-2-yl)butan-1-one (3f).1 
Purified by column chromatography (SiO2, 50% EtOAc:hexanes). 1H-NMR (CDCl3, 400 
MHz) δ 1.41 (d, 3H, J = 6.9 Hz), 3.39 (dd, 1H, J = 8.3 Hz, J = 15.6 Hz), 3.58 (dd, 1H, J = 
6.2, J = 15.6 Hz), 3.77 – 3.84 (m, 1H), 3.86 (s, 3H), 3.94 (s, 3H), 6.82 (dd, 1H, J = 2.5 
Hz, 8.8 Hz), 7.00 (s, 1H), 7.03 (d, 1H, J = 2.4 Hz), 7.15 (s, 1H), 7.15 – 7. 16 (m, 1H), 
7.20 (s, 1H), 7.21 (d, 1H, J = 8.8 Hz), 8.05 (s, 1H). 13C-NMR (CDCl3, 400 MHz) δ 21.5 
(q), 27.2 (q), 36.2 (d), 46.7 (q), 55.9 (t), 101.0 (d), 111.7 (d), 112.1 (d), 120.9 (d), 121.2 
(s), 126.9 (d), 126.9 (s), 128.9 (d), 131.5 (s), 143.3 (s), 153.7 (s), 192.4 (s). HRMS (ESI) 
calcd for C17H20N3O2: 298.1550 ([M+H])+, found 298.1550 ([M+H])+. HPLC: Chiralcel-
AD, heptane/iPrOH 90:10, flow 1 mL/min, tr 33.4 (+) and 40.0 (-) mins. 
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dimethyl 2-(3-(1-methyl-1H-imidazol-2-yl)-3-oxo-1-phenylpropyl)malonate (5)2 
A colourless oil was obtained after column chromatography (SiO2, EtOAc/hexane 4:6). 
1H-NMR (CDCl3, 400 MHz, 300 K) δ=7.26 (d, J = 7.2 Hz, 2H), 7.19 (t, J = 7.2 Hz, 2H), 
7.11 (d, J = 6.9 Hz, 1H), 7.03 (d, J = 0.9 Hz, 1H), 6.91 (s, 1H), 4.13 (td, J = 4.5, 9.8 Hz, 
1H), 3.84-3.76 (m, 2H), 3.80 (s, 3H), 3.67 (s, 3H), 3.45-3.39 (m, 1H), 3.41 (s, 3H); 13C-
NMR (CDCl3, 50 MHz, 300 K) δ=189.7, 168.7, 168.2, 143.0, 140.6, 129.1, 128.5, 128.4, 
127.2, 127.1, 57.8, 52.8, 52.5, 42.9, 40.5, 36.1; HRMS: m/z: 344.1366 [M+] (Calcd 




A white solid was obtained after purification by column chromatography (SiO2, 
EtOAc/hexane 4:6). m.p. 93.4°C; 1H-NMR (CDCl3, 400 MHz, 300 K) δ=7.38-7.20 (m, 
5H), 7.09 (d, J = 0.9 Hz, 1H), 6.99 (s, 1H), 4.72 (dd, J = 6.8, 12.5 Hz, 1H), 4.62 (dd, J = 
8.3, 12.5 Hz, 1H), 4.19 (quint, J = 7.2 Hz, 1H), 3.90 (s, 3H), 3.70 (dd, J = 7.2, 17.4 Hz, 
1H), 3.46 (dd, J = 7.2, 17.4 Hz, 1H); 13C-NMR (CDCl3, 50 MHz, 300 K) δ=189.3, 142.7, 
139.2, 129.5, 129.1, 127.9, 127.7, 127.6, 80.1, 42.0, 39.5, 36.3; MS (CI): m/z (%): 274.2 
(100) [M+H+] (Calcd 274.1). HPLC: Chiralpak-AD, n-heptane/iPrOH 95:5, flow 1 
ml/min, tr  28.4 and 35.0 min. 
 
 
                                                 
1 A.J. Boersma, B.L. Feringa and G. Roelfes, Angew. Chem. Int. Ed. 2009, 48, 3346. 
2 D. Coquière, B.L. Feringa and G. Roelfes, Angew. Chem. Int. Ed. 2007, 46, 9308. 
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